Hints and tips:
Related Special Reports
...“We’re very much interested in a European listing”, said Juan Martinez, the head of Curaleaf International, who added that current restrictions meant “the only listing in Europe that is possible is a very...
...“[Biotech] is a very important [industry] and it’s one where the continent has an edge, but we’re not really using that edge, because we’re lacking the financial firepower the US funds have,” he said....
...“If you look at how we are scaling up API capacity, we’re scaling to serve many more patients,” he said. “The more we go oral, the less we can give injectables.”...
...“So you have to tread carefully anywhere, you’re in a regulated industry, but I don’t think it’s something that is in the forefront for us now,” he said....
...GHO’s decision to put the Porto-based contract research organisation up for sale followed bidder interest, the people said, and comes amid an accelerating shift towards outsourcing in the pharmaceutical...
...“We’re well positioned to be leaders in the broader field [of radioconjugates].”...
...“We’re pleased to work with Lilly to reimagine a pharmacy experience that can support better care outcomes.”...
...“There was a time in that transition where the market wasn’t necessarily following where they were in their turnaround,” she said. “We’re in that moment right now.”...
...The findings come after the UK set up a Critical Imports Council on Wednesday made up of 23 industry leaders, which will advise on supply chain resilience for vital goods including medicines and semiconductors...
...Michela Tindera While Novo Nordisk has enjoyed this recent explosion of success, the journey to get here has taken a long time, even by the standards of the pharmaceutical industry....
...But another western diplomat warned that the industry “hates transactionality . . . the idea that a country that detects a novel pathogen that has massive pandemic risk can say, ‘No, we’re not going to share...
...The country is home to the third-largest pharmaceutical market in the world. There is still room for growth in Japan’s $53bn dispensing pharmacy market....
...It’s a funny phrase because it makes perfect sense in the pharmaceutical context — they’re contractors who manufacture drugs and help with some of the development process — but also sounds a bit like they...
...The pharmaceutical industry is close to agreeing a deal with the UK government over drug pricing, according to the chief financial officer of Swiss drugmaker Novartis....
...and vulnerable to supply shocks, quality defects or surges in demand, say industry leaders and analysts....
...Under the VPAG deal, which comes into force in 2024, the pharmaceutical industry agreed to invest an additional £400mn over five years through the UK life sciences investment programme “to drive forward...
...Pharmaceutical companies also have a key role to play in providing affordable access to these essential products. The global industry’s response to date has been inadequate and fragmented....
...But after years of trying, the pharmaceuticals industry is getting to grips with the multibillion-dollar problem of fatty liver disease....
...According to the European Federation of Pharmaceutical Industries and Associations, a Brussels-based lobby group, the US attracted a third more R&D investment than Europe in 2010....
...That ambition, the Association of the British Pharmaceutical Industry says, is contingent on “[making] sure we do not forget the lessons we learned during the pandemic”....
...Maag said it may take longer for fundraising to rebound for the riskiest companies, but added: “If you have good clinical data and know what you’re doing, I think companies are financeable right now.”...
...Today, we look at a hot topic rocking the healthcare industry and beyond: obesity drugs....
...This is the highest level of activity since the last quarter of 2021 when the industry was still riding a wave of investor exuberance because of the Covid-19 pandemic, according to data from Dealogic....
...But the proposal has run into opposition from the pharmaceutical industry....
...“We’re about 20 years behind cancer,” she said....
International Edition